WO2006132950A3 - Therapeutic polymers and methods of use - Google Patents

Therapeutic polymers and methods of use Download PDF

Info

Publication number
WO2006132950A3
WO2006132950A3 PCT/US2006/021395 US2006021395W WO2006132950A3 WO 2006132950 A3 WO2006132950 A3 WO 2006132950A3 US 2006021395 W US2006021395 W US 2006021395W WO 2006132950 A3 WO2006132950 A3 WO 2006132950A3
Authority
WO
WIPO (PCT)
Prior art keywords
therapeutic
poly
polymer
polymer compositions
ester
Prior art date
Application number
PCT/US2006/021395
Other languages
French (fr)
Other versions
WO2006132950A2 (en
Inventor
William G Turnell
Zaza D Gomurashvili
Ramaz Katsarava
Original Assignee
Medivas Llc
William G Turnell
Zaza D Gomurashvili
Ramaz Katsarava
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medivas Llc, William G Turnell, Zaza D Gomurashvili, Ramaz Katsarava filed Critical Medivas Llc
Priority to CA002610745A priority Critical patent/CA2610745A1/en
Priority to AU2006255262A priority patent/AU2006255262A1/en
Priority to JP2008514885A priority patent/JP2008542393A/en
Priority to EP06760640A priority patent/EP1906976A4/en
Publication of WO2006132950A2 publication Critical patent/WO2006132950A2/en
Publication of WO2006132950A3 publication Critical patent/WO2006132950A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A61K48/0008—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'non-active' part of the composition delivered, e.g. wherein such 'non-active' part is not delivered simultaneously with the 'active' part of the composition
    • A61K48/0025—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'non-active' part of the composition delivered, e.g. wherein such 'non-active' part is not delivered simultaneously with the 'active' part of the composition wherein the non-active part clearly interacts with the delivered nucleic acid
    • A61K48/0041—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'non-active' part of the composition delivered, e.g. wherein such 'non-active' part is not delivered simultaneously with the 'active' part of the composition wherein the non-active part clearly interacts with the delivered nucleic acid the non-active part being polymeric
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A61K47/593—Polyesters, e.g. PLGA or polylactide-co-glycolide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A61K47/595—Polyamides, e.g. nylon
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G71/00—Macromolecular compounds obtained by reactions forming a ureide or urethane link, otherwise, than from isocyanate radicals in the main chain of the macromolecule
    • C08G71/04—Polyurethanes
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L77/00—Compositions of polyamides obtained by reactions forming a carboxylic amide link in the main chain; Compositions of derivatives of such polymers
    • C08L77/12—Polyester-amides

Abstract

The present invention provides biodegradable therapeutic polymer compositions based on poly(ester amide) (PEA), poly(ester urethane) (PEUR), and poly(ester urea) (PEU) polymers useful for in vivo delivery of at least one therapeutic diol or di-acid incorporated into the backbone of the biodegradable polymer. The therapeutic polymer compositions biodegrade in vivo by enzymatic action to release therapeutic diols or di-acids from the polymer backbone in a controlled manner over time. The invention compositions are stable, can be lyophilized for transportation and storage, and can be redispersed for administration. Due to structural properties of the PEA and PEUR polymers used, the invention therapeutic polymer compositions provide for high loading of the therapeutic diol or di-acid, as well as optional bioactive agents.
PCT/US2006/021395 2005-06-03 2006-06-02 Therapeutic polymers and methods of use WO2006132950A2 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
CA002610745A CA2610745A1 (en) 2005-06-03 2006-06-02 Therapeutic polymers and methods of use
AU2006255262A AU2006255262A1 (en) 2005-06-03 2006-06-02 Therapeutic polymers and methods of use
JP2008514885A JP2008542393A (en) 2005-06-03 2006-06-02 Therapeutic polymers and methods of use
EP06760640A EP1906976A4 (en) 2005-06-03 2006-06-02 Therapeutic polymers and methods of use

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US68757005P 2005-06-03 2005-06-03
US60/687,570 2005-06-03
US75917906P 2006-01-13 2006-01-13
US60/759,179 2006-01-13

Publications (2)

Publication Number Publication Date
WO2006132950A2 WO2006132950A2 (en) 2006-12-14
WO2006132950A3 true WO2006132950A3 (en) 2007-06-14

Family

ID=37498935

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2006/021395 WO2006132950A2 (en) 2005-06-03 2006-06-02 Therapeutic polymers and methods of use

Country Status (5)

Country Link
EP (1) EP1906976A4 (en)
JP (1) JP2008542393A (en)
AU (1) AU2006255262A1 (en)
CA (1) CA2610745A1 (en)
WO (1) WO2006132950A2 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9102830B2 (en) 2005-09-22 2015-08-11 Medivas, Llc Bis-(α-amino)-diol-diester-containing poly (ester amide) and poly (ester urethane) compositions and methods of use
US9517203B2 (en) 2000-08-30 2016-12-13 Mediv As, Llc Polymer particle delivery compositions and methods of use

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7273469B1 (en) 2003-12-31 2007-09-25 Advanced Cardiovascular Systems, Inc. Modified needle catheter for directional orientation delivery
JP2009530484A (en) * 2006-03-24 2009-08-27 メディバス エルエルシー Biodegradable poly (ester-amide) containing alkylene-dicarboxylate and method of use
WO2007133616A2 (en) * 2006-05-09 2007-11-22 Medivas, Llc Biodegradable water soluble polymers
US20080200377A1 (en) * 2007-02-16 2008-08-21 Trollsas Mikael O Polymer particles
EP2227223A4 (en) * 2007-12-06 2013-11-27 Medivas Llc Oligo-ethylene glycol-based polymer compositions and methods of use
EP2723800B1 (en) 2011-06-23 2015-10-07 DSM IP Assets B.V. Micro- or nanoparticles comprising a biodegradable polyesteramide copolymer for use in the delivery of bioactive agents
US9873765B2 (en) 2011-06-23 2018-01-23 Dsm Ip Assets, B.V. Biodegradable polyesteramide copolymers for drug delivery
US10434071B2 (en) 2014-12-18 2019-10-08 Dsm Ip Assets, B.V. Drug delivery system for delivery of acid sensitivity drugs
CA2988679A1 (en) 2015-06-23 2016-12-29 Phagelux (Canada), Inc. Composition comprising amino acid polymers and a bioactive agent and method of preparing thereof
CN110804175B (en) * 2019-11-08 2021-05-14 中国科学院理化技术研究所 Antibacterial polyamino acid derivative or copolymer with alternating structure and preparation method thereof

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6503538B1 (en) * 2000-08-30 2003-01-07 Cornell Research Foundation, Inc. Elastomeric functional biodegradable copolyester amides and copolyester urethanes
US20040098118A1 (en) * 2002-09-26 2004-05-20 Endovascular Devices, Inc. Apparatus and method for delivery of mitomycin through an eluting biocompatible implantable medical device

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001051027A2 (en) * 2000-01-11 2001-07-19 Intralytix, Inc. Polymer blends as biodegradable matrices for preparing biocomposites
US6703040B2 (en) * 2000-01-11 2004-03-09 Intralytix, Inc. Polymer blends as biodegradable matrices for preparing biocomposites
CA2771263A1 (en) * 2000-07-27 2002-02-07 Rutgers, The State University Therapeutic polyesters and polyamides
US8765164B2 (en) * 2005-10-21 2014-07-01 Kenneth W. Carpenter Poly(ester urea) polymers and methods of use

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6503538B1 (en) * 2000-08-30 2003-01-07 Cornell Research Foundation, Inc. Elastomeric functional biodegradable copolyester amides and copolyester urethanes
US20040098118A1 (en) * 2002-09-26 2004-05-20 Endovascular Devices, Inc. Apparatus and method for delivery of mitomycin through an eluting biocompatible implantable medical device

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of EP1906976A4 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9517203B2 (en) 2000-08-30 2016-12-13 Mediv As, Llc Polymer particle delivery compositions and methods of use
US9102830B2 (en) 2005-09-22 2015-08-11 Medivas, Llc Bis-(α-amino)-diol-diester-containing poly (ester amide) and poly (ester urethane) compositions and methods of use

Also Published As

Publication number Publication date
CA2610745A1 (en) 2006-12-14
JP2008542393A (en) 2008-11-27
WO2006132950A2 (en) 2006-12-14
AU2006255262A1 (en) 2006-12-14
EP1906976A4 (en) 2011-11-09
EP1906976A2 (en) 2008-04-09

Similar Documents

Publication Publication Date Title
WO2006132950A3 (en) Therapeutic polymers and methods of use
WO2007050415A3 (en) Poly(ester urea) polymers and methods of use
WO2007130477A3 (en) Delivery of ophthalmologic agents to the exterior or interior of the eye
Talebian et al. Self‐healing hydrogels: the next paradigm shift in tissue engineering?
WO2007112046A3 (en) Alkylene-dicarboxylate-containing biodegradable poly(ester amides) and methods of use
WO2007133616A3 (en) Biodegradable water soluble polymers
WO2008021548A3 (en) Epoxy-containing poly(ester amides) and methods of use
WO2008048298A3 (en) Polymer particles for delivery of macromolecules and methods of use
Schutgens et al. Biomaterials for intervertebral disc regeneration: past performance and possible future strategies.
PL2244752T3 (en) Low viscosity liquid polymeric delivery system
WO2007035938A3 (en) BIS-(α-AMINO)-DIOL-DIESTER-CONTAINING POLY(ESTER AMIDE) AND POLY(ESTER URETHANE) COMPOSITIONS AND METHODS OF USE
WO2007069068A3 (en) Cell penetrating peptide conjugates for delivering nucleic acids into cells
WO2006097355A8 (en) Biodegradable aliphatic-aromatic copolyester
WO2006108009A3 (en) Controlled degradation materials for therapeutic agent delivery
JP2012514121A5 (en)
MX347056B (en) Pharmaceutical compositions.
WO2008094834A3 (en) Multi-functional drug carriers
MX2010001219A (en) Tunably crosslinked hyaluronic acid compositions.
WO2010005723A3 (en) Drug loaded polymeric nanoparticles and methods of making and using same
EP1932863A3 (en) Soft thermoplastic polyurethane elastomers and processes for their preparation and use
WO2001051027A3 (en) Polymer blends as biodegradable matrices for preparing biocomposites
WO2011112482A3 (en) Polymeric drug delivery conjugates and methods of making and using thereof
WO2006022754A3 (en) Radiopaque polymeric stents
GB0620685D0 (en) Bioresorbable polymers
Shariatzadeh et al. Injectable and reversible preformed cryogels based on chemically crosslinked gelatin methacrylate (GelMA) and physically crosslinked hyaluronic acid (HA) for soft tissue engineering

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application
ENP Entry into the national phase

Ref document number: 2008514885

Country of ref document: JP

Kind code of ref document: A

ENP Entry into the national phase

Ref document number: 2610745

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 12007502735

Country of ref document: PH

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2006255262

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 2006760640

Country of ref document: EP

ENP Entry into the national phase

Ref document number: 2006255262

Country of ref document: AU

Date of ref document: 20060602

Kind code of ref document: A